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Invited commentary
Cardiovascular MR angiography
MRA is revolutionizing diagnosis of vascular pathology. Accurate diagnosis of cardiovascular pathology
without requiring the risks of arterial catheterization, ionizing radiation and nephrotoxic contrast agents has
been an ongoing challenge. Two articles in this issue of Cardiovascular MR by Stilman and Westenberg et
al., demonstrate how advances in MR angiography now allow accurate diagnosis of peripheral vascular,
renal, aortic and coronary artery bypass graft pathology.
This is possible because of the introduction of several advances described by these authors. MR imaging
systems have substantially improved gradient performance that allows rapid imaging of extensive volumes
of vascular anatomy during breathholding [1]. Some scanners are even fast enough to chase a contrast agent
bolus down the legs to provide an anatomic map of the arterial anatomy of the entire lower half of the body
with a single injection of contrast [2±6]. Another important advance is the understanding of how to
optimize the imaging parameters. Many studies including that of Westenberg et al. show how the signal-to-
noise ratio of the MR angiograms can be maximized by careful selection of the pulse sequence and imaging
parameters. Perhaps the most important advance is the availability of gadolinium based paramagnetic
contrast agents [7]. We now know these contrast agents to be free of clinically detectable nephrotoxicity
even at high doses [8±9]. The gadolinium chelates currently in clinical use also have a very low incidence of
allergic reactions [10]. A history of allergy to iodinated contrast is not a contraindication to gadolinium
enhanced MR angiography and premedication with steroids or histamine blockers is not necessary. Using
gadolinium chelates enormously increases the signal to noise ratio of the MR images. Higher quality studies
are easily obtained by either using more gadolinium contrast or by injecting the gadolinium contrast faster
for a higher arterial contrast agent concentration. New contrast agents with higher relaxivity are also in
clinical testing [11]. Combined with the faster imaging hardware which can complete scans in a shorter
amount of time, these fast contrast agent injections do not need to last very long and so the dose of contrast
required for high signal to noise images is becoming less and less. Repeat injections of contrast are also
possible although Westenberg et al. shows that repeat injections never enhance as well as the ®rst because
of background tissue accumulation of the contrast agent.
The advances in MR imaging system hardware and software have made imaging faster and image quality
better but at the expense of making contrast agent bolus timing more critical. Both Stilman and Westenberg
emphasize the importance of bolus timing for successful contrast enhanced MRA. In addition to the test
bolus strategy or automatic detection (MR Smart Prep), described in their articles, it is also possible to
improve bolus timing using MR ¯uoroscopy [12] super fast multiphase imaging [13] or 3D-TRICKS [14].
With MR ¯uoroscopy the arrival of contrast agent in the arteries is observed in real time so that the high
resolution 3D spoiled gradient echo MRA sequence can be activated when the contrast arrives in the artery
of interest for perfect synchronization of central k-space data acquision with the arterial phase of the bolus
[15]. With multiphase imaging or 3D-tricks, the 3D imaging volume is acquired repeatedly at such short
intervals that a bolus injection of gadolinium contrast agent will provide arterial phase enhancement for at
least one entire 3D volume acquisition. For the test bolus timing strategy, we prefer to use an ultrasound
content agent such as Optison (Mallinckrodt, St. Louis). This has several advantages: it does not introduce
any gadolinium contrast into the patient prior to the MRA sequence. It can easily be repeated multiple
times because it is very safe and only requires 0.1±0.3 ml to measure the circulation time and it disappears
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in about three minutes. Furthermore, since the ultrasound bubbles are detected with an ultrasound scanner,
this can be done outside the MR imaging system prior to the study to reduce the required magnet time.
As the quality of MRA improves, diagnostic accuracy and clinical utility also improves. But the details of
image acquisition including parameter optimization from one patient to the next, breathholding, bolus
timing and k-space mapping are becoming more and more complex. There are also subtle Fourier artifacts
and computer reconstruction artifacts which must be understood to avoid diagnostic errors. This increases
the training requirement for radiologists performing and interpreting these studies. It is essential to learn
both the underlying physics and the clinical implementation for various anatomic regions. This is especially
important as we take on the challenge of imaging smaller and smaller arteries that move with respiration
and with cardiac contraction [16]. A whole new ®eld of cardiovascular MR is emerging to revolutionize the
diagnosis of vascular pathology. The barbaric days of arterial punctures, ionizing radiation and nephro-
toxic poisons are giving way to the safe accurate patient-friendly approach of cardiovascular MR.
References
1. Leung DA, Mckinnon GC, Davis CPfammatter T, Krestin GP, Debatin JF. Breathhold, contrast-enhanced, three-dimensional MR
angiography. Radiology 1996; 200: 569±571.
2. Wang Y, Lee HM, Khilnani NM, Trost DW, Jagust MB, Winchester PA, Bush HL, Sos TA, Sostman HD. Bolus-chase MR digital
subtraction angiography in the lower extremity. Radiology 1998; 207: 263±269.
3. Maki JH, Chenevert TL, Prince MR. Three-dimensional contrast-enhanced MR angiography. Topics in MRI 8: 322±344, 1996.
4. Meaney JFM, Ridgway, Radjenovic, Saysell M, Kouwenhoven M, Kassner A, Smith MA. Stepping Table Gadolinium-enhanced
digital substraction MRA of the aorta and lower extremity arteries, ISMRM 1998; Volume 1 page 66.
5. Foo TKF, Ho VB, McCann RA, Moalemi A, Hood MN. Single bolus contrast enhanced peripherals 3D MRA using automated table
motion integrated with automated bolus detection and acquisition triggering, ISMRM. 1998; vol 1, page 67.
6. Ho KY, Leiner T, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheral vascular tree stenoses: evaluation with
moving-bed infusion-tracking MR angiography. Radiology 1998; 206: 683±692.
7. Weinmann HJ, Brashch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast
agent. AJR AM J Roentgenol 1984; 142: 619±624.
8. Haustein J, Niendorf HP, Krestin G, Louton T, Schuhmann-Giampieri G, Clauss W, Junge W. Renal tolerance of Gd-DTPA/
dimeglumine in patients with chronic renal failure. Invest Radiol 1992; 27: 153±156.
9. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high dose gadolinium compared to iodinated contrast. J Magn Reson
imaging 1996; 6: 162±166.
10. Murphy KJ, Brunberg JA, Cohan RH: Adverse reactions to gadolinium contrast media: A review of 36 cases. AJR Am J
Roentgenol 167: 847±849, 1996.
11. Grist TM, Korosec FR, Peters DC, Witte S, Walovitch RC, Dolan RP, Birdson WE, Yucel EK, Mistretta CA. Steady-state and
dynamic MR angiography with MS-325: intial experience in humans. Radiology 1998; 207: 539±544.
12. Wilman AH, Riederer SJ, King BF, Debbins JP, Rossman PJ, Ehman RL. Fluoroscopically triggered contrast-enhanced three-
dimensional MR angiography with elliptical centric view order: application to the renal arteries. Radiology 1997; 205: 137±146.
13. Schoenberg SO, Knopp MV, Prince MR, Londy F, Knopp MA. Arterial-phase three-dimension godolinium magnetic resonance
angiography of the renal arteries. Investigative Radiology 1998; 9: 506±514.
14. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;
36: 345±351.
15. Maki JM, Prince MR, Londy FJ, Chenevert TL. The eects of time varying intravascular signal intensity and k-space acquisition
order on three-dimensional MR angiography image quality. J Magn Reson Imaging 1996; 6: 642±651.
16. Duerinck AJ. Coronal MR Angiography. MRI Clinics of N.A. 1996; 4: 361±418.
Martin R. Prince
Jonathan M. Rubin
University of Michigan Medical Center
Department of Radiology,
1500 East Medical Center Drive
Ann Arbor, MI, 48109-0030 USA
Fax: 734 764 2412
116
